X

Drug Profile

CP 118

Alternative Names: COL 118; CP118

Latest Information Update: 20 Mar 2014

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Collegium Pharmaceutical
Class Antihistamines
Mechanism of Action Histamine receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Discontinued Allergic rhinitis

Most Recent Events

20 Mar 2014 Discontinued - Phase-II for Allergic rhinitis in USA (PO)
27 May 2009 Efficacy data from a phase II trial in Allergic rhinitis released by Collegium
07 Mar 2007 Results from a phase II clinical trial in patients with Allergic rhinitis have been added to the adverse events section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com